BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 25481052)

  • 1. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies.
    Micel LN; Tentler JJ; Smith PG; Eckhardt GS
    J Clin Oncol; 2013 Mar; 31(9):1231-8. PubMed ID: 23358974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
    Burger AM; Seth AK
    Eur J Cancer; 2004 Oct; 40(15):2217-29. PubMed ID: 15454246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
    Allende-Vega N; Saville MK
    Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of ubiquitin proteasome pathway in cancer development.
    Yerlikaya A; Yƶntem M
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Therapeutic Deubiquitylase Effector Molecules: Current Perspectives.
    Nicholson B; Kumar S; Agarwal S; Eddins MJ; Marblestone JG; Wu J; Kodrasov MP; LaRocque JP; Sterner DE; Mattern MR
    J Biomol Screen; 2014 Aug; 19(7):989-99. PubMed ID: 24632661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways: translational potential of deubiquitinases as drug targets.
    D'Arcy P; Linder S
    Clin Cancer Res; 2014 Aug; 20(15):3908-14. PubMed ID: 25085788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
    Lub S; Maes K; Menu E; De Bruyne E; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Feb; 7(6):6521-37. PubMed ID: 26695547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
    Satija YK; Bhardwaj A; Das S
    Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting E3 ubiquitin ligases for cancer therapy.
    Sun Y
    Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.
    Eisele F; Wolf DH
    FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4: a promising target for cancer therapy.
    Ye X; Wang L; Shang B; Wang Z; Wei W
    Curr Cancer Drug Targets; 2014; 14(6):549-56. PubMed ID: 25088038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
    Lill JR; Wertz IE
    Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.
    Di Gregorio J; Appignani M; Flati V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on natural products for drug development].
    Tsukamoto S
    Yakugaku Zasshi; 2010 Oct; 130(10):1273-81. PubMed ID: 20930478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining protein stability and its relevance for plant growth and development.
    Schwechheimer C; Willige BC; Zourelidou M; Dohmann EM
    Methods Mol Biol; 2009; 479():147-71. PubMed ID: 19083189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis.
    Liu CH; Goldberg AL; Qiu XB
    Chang Gung Med J; 2007; 30(6):469-79. PubMed ID: 18350730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.